PEPFAR in transition - Implications for HIV care in South Africa

New England Journal of Medicine

Volumn 369, Issue 15, 2013, Pages 1385-1387

  Katz, Ingrid T ^a   Bassett, Ingrid V ^a   Wright, Alexi A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885617665     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1310982     Document Type: Article

References (5)

1. Chigwedere P, Seage GR III, Gruskin S, Lee TH, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr 2008;49:410-5.
2. Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA 2012;307:2060-7.
3. Bor J, Herbst AJ, Newell ML, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013;339:961-5.
4. Bassett IV. Large scale, rapid transfer of HIV-infected patients from hospital-based to primary health clinics in South Africa: an assessment of self-reported linkage to care. Presented at the 8th International Conference on HIV Treatment and Prevention Adherence, Miami, June 2-4, 2013.
5. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011;25:2177-81.